Castleman’s Disease. Association with System Scleroderma
https://doi.org/10.20514/2226-6704-2023-13-5-385-391
Abstract
The article presents an observation of a rare benign lymphoproliferative disease — Castleman’s disease, with pronounced systemic symptoms. The clinical case is of interest not only for the rarity of pathology, but also for the peculiarities of clinical manifestations, including paraneoplastic pseudosclerodermic clinical and immunological syndrome, which was not previously described in the context of Castleman’s disease, Raynaud’s syndrome, severe pulmonary hypertension and a suspected (not proven morphologically) variant of extranodal lesion with its previously also not
observed localization in the sigmoid colon wall.
Supporting agencies: The authors declare no funding for this study
About the Authors
A. V. Yagoda
Stavropol State Medical University
Russian Federation
Russian Federation
Aleksandr V. Yagoda
Department of Hospital Therapy
Stavropol
P. V. Koroy
Stavropol State Medical University
Russian Federation
Russian Federation
Department of Hospital Therapy
Stavropol
D. P. Kharchenko
Stavropol Regional Clinical Hospital
Russian Federation
Russian Federation
Stavropol
E. V. Bondarenko
Stavropol State Medical University
Russian Federation
Russian Federation
Department of Hospital Therapy
Stavropol
References
1. O´Shea J.J., Murray P.J. Cytokine signaling modules in inflammatory responses. Immunity. 2008; 28(4):477-487. doi: 10.1016/j.immuni.2008.03.002
2. Dispenzieri A. POEMS syndrome. Blood Rev. 2007; 21(6): 285-299. doi: 10.1016/j.blre.2007.07.004
3. Keller A.R., Hochholzer L., Castleman B. Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972; 29(3): 670-683. URL: https://www.semanticscholar.org/paper/Hyaline%E2%80%90vascular-and-plasma%E2%80%90cell-types-of-giant-of-Keller-Hochholzer/cf9fac962c1947b895355d02025f34614e78fb87
4. Melikyan A.L., Egorova E.K. Castleman disease (literature review). Oncohematology. 2016; 11(2): 8-20. doi: 10.17650/1818-8346-2016-11-2-8-20. [In Russian]
5. Vasilyev V.I., Palshina S.G., Pavlovskaya A.I. et al. Idiopathic multicentric Castleman’s disease. Therapeutic archive. 2020; 92 (5):78-84. doi: 10.26442/00403660.2020.05.000440. [In Russian]
6. Frizzera G. Сastleman’s disease and related disorders. Semin Diagn Pathol. 1988; 5(4): 346-364. PMID: 2464187
7. Melikyan A.L., Egorova E.K., Kovrigina A.M. et al. Clinical and morphological features of different types of Castleman’s disease. Therapeutic archives. 2015; 87(7): 64-71. doi: 10.17116/terarkh201587764-71. [In Russian]
8. Wang Hao-Wey, Pittaluga S., Jaffe E.S. Multicentric Castleman’s disease: Where are we now? Semin Diagn Pathol. 2016; 33: 294-306. doi: 10.1053/j.semdp.2016.05.006
9. Liu A.Y., Nabel C.S., Finkelman B.S. et al. Idiopathic multicentric Castleman’s disease: a systematic literature review. Lancet Hematol. 2016; 3(4): е163-е175. doi: 10.1016/s2352-3026(16)00006-5
10. Ko S.F., Hsieh M.J., Ng S.H. et al. Imaging spectrum of Castleman’s disease. Am J Roentgenol. 2004; 182(3): 769-775. doi: 10.2214/ajr.182.3.1820769
11. Reddy M.P., Graham M.M. FDG positron emission tomographic imaging of thoracic Castleman’s disease. Clin Nucl Med. 2003; 28(4): 325-326. doi: 10.1097/01.RLU.0000057615.73933.2F
12. Grimm K.E., Barry T.S., Chizhevsky V. et al. Histopathological findings in 29 lymph node biopsies with increased IgG4 plasma cells. Modem Pathol. 2012; 25: 480-491. doi: 10.1038/modpathol.2011.177
13. Sato Y., Kojima M., Takata K. et al. Multicentric Castleman’s disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol. 2010; 63: 1084-1089. doi: 10.1136/jcp.2010.082958
14. Kaplan L.D. Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. Hematology Am Soc Hematol Educ Program. 2013; 2013: 103-108. doi: 10.1182/asheducation-2013.1.103
15. Haque S., van Kirk R. Three patients with both Hodgkin’s lymphoma and Castleman’s disease: Сlinicopathologic correlations and lack of association with HHV-8. Indian J Med Paediatr Oncol. 2009; 30(2): 76-79. doi: 10.4103/0971-5851.60052
16. Nishimoto N., Kishimoto T., Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis. 2000; 59(suppl 1): 121-127. doi: 10.1136/ard.59.suppl_1.i21
17. Nasr M.R., Perry A.M., Scrubik P. Lymph Nodes Pathology of for Clinicians. Edited by Yu.A. Krivolapov. M.: Practical Medicine. 2020; 224 p. [In Russian]
18. Simko R., Nagy K., Lombay B. et al. Multicentric Castleman disease and systemic lupus erythematosus phenotype in a boy with Klinefelter syndrome: long-term disease stabilization with interferon therapy. J Pediatr Hematol Oncol. 2000; 22(2): 180-183. doi: 10.1097/00043426-200003000-00021
19. Greiner T., Armitage J.O., Gross T.G. Atypical lymphoproliferative disease. Hematology. 2000; 1: 133-154. doi: 10.1182/asheducation-2000.1.133
20. Shirokova I.E., Lisiezina T.A., Rudenska-Lopovok S.G. Systemic lupus erythematosus or Kastleman’s disease difficulties of diagnosis (case report and review of literature). Rheumatology Science and Practice. 2002; 40(3): 54-61. URL: https://rsp.mediar-press.net/rsp/article/view/1130 [In Russian]
21. Guseva N.G. Systemic scleroderma and pseudosclerodermic syndromes. RAMS. M.: Medicine. 1993; 270 p. [In Russian]
22. Pulmonary hypertension / Edited by I.E. Chazova, T.V. Martynyuk. M.: Praktika. 2015; 928 p. [In Russian]
23. Mathai S.P., Hassoun P.M. Pulmonary arterial hypertension in connective tissue diseases. Heart Fail Clin. 2012; 8(3): 413-425. doi: 10.1016/j.hfc.2012.04.001
24. Mikhailov A.M., Bessmeltsev S.S., Potapenko V.G. et al. The Castleman disease, POEMS-syndrome and productive vasculitis in microvascular network of different tissues. Sibirskij nauchnyj medicinskij zhurnal = Siberian Scientific Medical Journal. 2019; 39(1): 119-124. doi: 10.15372/SSMJ20190117 [In Russian]
Review
For citations:
Yagoda A.V., Koroy P.V., Kharchenko D.P., Bondarenko E.V. Castleman’s Disease. Association with System Scleroderma. The Russian Archives of Internal Medicine. 2023;13(5):385-391. https://doi.org/10.20514/2226-6704-2023-13-5-385-391
Views:
416
Email this article 